NBRV News and Press, Nabriva Therapeutics plc From 01/23/20

The WSJ reports that the coronavirus responsible for the current outbreak in China, mainly in the city of Wuhan, appears less virulent than the virus responsible for the SARS outbreak in 2003. More news on: Moderna, Inc., NanoViricides, Inc., Novavax, Inc., Healthcare stocks news, Stocks...

Later today, the U.S. Centers for Disease Control and Prevention will brief the media on the coronavirus outbreak in China that has stricken 291 people and killed six, mostly in the city of Wuhan in Hubei province. More news on: NanoViricides, Inc., Novavax, Inc., Inovio Pharmaceuticals, I...

Applied Genetic Technologies (NASDAQ: AGTC ) +53%  on positive XLRP data . More news on: Applied Genetic Technologies Corporation, VBI Vaccines Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...

Have you ever traded penny stocks or are you just getting your feet wet with these low priced stocks? No matter what kind of experience you have, it’s a safe bet that you know these types of stocks are risky. But that doesn’t mean they aren’t profitable. In fact, if you...

The FDA accepts for revie w Nabriva Therapeutics' (NASDAQ: NBRV ) resubmitted marketing application for Contepo (fosfomycin) for the treatment of complicated urinary tract infections. The agency's action date is June 19. More news on: Nabriva Therapeutics plc, Healthcare stocks news, Stoc...

DUBLIN, Ireland, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, announced that the U.S. Food and Drug Administration (FDA) has...

Gainers:  Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...

Stealth BioTherapeutics (NASDAQ: MITO )  -56%  after elamipretide flunks late-stage PMM study. More news on: Stealth BioTherapeutics Corp, Valeritas Holdings, Inc., Abeona Therapeutics Inc., Stocks on the move, Read more ...

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has ente...

-Nabriva anticipates a six-month review period by the Food and Drug Administration -CONTEPO is a potential first-in-class intravenous antibiotic in U.S. for the treatment of complicated urinary tract infections DUBLIN, Ireland, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc...